Stuart Koelewijn

513 total citations
12 papers, 412 citations indexed

About

Stuart Koelewijn is a scholar working on Oncology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Stuart Koelewijn has authored 12 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Epidemiology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Stuart Koelewijn's work include Neuroendocrine Tumor Research Advances (7 papers), Lung Cancer Research Studies (7 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Stuart Koelewijn is often cited by papers focused on Neuroendocrine Tumor Research Advances (7 papers), Lung Cancer Research Studies (7 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Stuart Koelewijn collaborates with scholars based in Netherlands, Switzerland and Greece. Stuart Koelewijn's co-authors include Marion de Jong, Erik de Blois, Marleen Melis, Harald C. Groen, M. Siebelt, Marion de Jong, J.H. Waarsing, Harrie Weinans, Cristina Müller and Eric P. Krenning and has published in prestigious journals such as Cancer Research, Bone and Journal of Nuclear Medicine.

In The Last Decade

Stuart Koelewijn

12 papers receiving 403 citations

Peers

Countries citing papers authored by Stuart Koelewijn

Since Specialization

Citations

This map shows the geographic impact of Stuart Koelewijn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Koelewijn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Koelewijn more than expected).

Fields of papers citing papers by Stuart Koelewijn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Koelewijn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Koelewijn. The network helps show where Stuart Koelewijn may publish in the future.

Co-authorship network of co-authors of Stuart Koelewijn

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart Koelewijn. A scholar is included among the top collaborators of Stuart Koelewijn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart Koelewijn. Stuart Koelewijn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Title	Journal	Authors	Indexed citations
1	Influence of tumour size on the efficacy of targeted alpha therapy with 213Bi-[DOTA0,Tyr3]-octreotate	EJNMMI Research	Ho Sze Chan, Mark Konijnenberg et al.	36
2	In Vitro and In Vivo Application of Radiolabeled Gastrin-Releasing Peptide Receptor Ligands in Breast Cancer	Journal of Nuclear Medicine	Simone U. Dalm, John W.M. Martens et al.	56
3	Investigation of Factors Determining the Enhanced Permeability and Retention Effect in Subcutaneous Xenografts	Journal of Nuclear Medicine	Michiel Bolkestein, Erik de Blois et al.	39
4	Optimization of combined temozolomide and peptide receptor radionuclide therapy (PRRT) in mice after multimodality molecular imaging studies	EJNMMI Research	Joost Haeck, Stuart Koelewijn et al.	18
5	Optimized time‐resolved imaging of contrast kinetics (TRICKS) in dynamic contrast‐enhanced MRI after peptide receptor radionuclide therapy in small animal tumor models	Contrast Media & Molecular Imaging	Joost Haeck, Sandra T. van Tiel et al.	7
6	Inhibited osteoclastic bone resorption through alendronate treatment in rats reduces severe osteoarthritis progression	Bone	M. Siebelt, J.H. Waarsing et al.	63
7	Peptide receptor radionuclide therapy (PRRT) with [177Lu-DOTA0,Tyr3]octreotate in combination with RAD001 treatment: further investigations on tumor metastasis and response in the rat pancreatic CA20948 tumor model	EJNMMI Research	Stuart Koelewijn, Linda M. van der Graaf et al.	16
8	Increased physical activity severely induces osteoarthritic changes in knee joints with papain induced sulfate-glycosaminoglycan depleted cartilage	Arthritis Research & Therapy	M. Siebelt, Harald C. Groen et al.	51
9	Multimodality Imaging of Somatostatin Receptor–Positive Tumors with Nuclear and Bioluminescence Imaging	Molecular Imaging	Timo L.M. ten Hagen, Stuart Koelewijn et al.	3
10	mTOR Inhibitor RAD001 Promotes Metastasis in a Rat Model of Pancreatic Neuroendocrine Cancer	Cancer Research	Stuart Koelewijn, Linda M. van der Graaf et al.	40
11	Comparison of the binding and internalization properties of 12 DOTA-coupled and 111In-labelled CCK2/gastrin receptor binding peptides: a collaborative project under COST Action BM0607	European Journal of Nuclear Medicine and Molecular Imaging	Luigi Aloj, Michela Aurilio et al.	54
12	Dynamic and Static Small-Animal SPECT in Rats for Monitoring Renal Function After ¹⁷⁷Lu-Labeled Tyr³-Octreotate Radionuclide Therapy	Journal of Nuclear Medicine	Marleen Melis, M. Visser et al.	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact